G1 Therapeutics Inc. (GTHX)
NASDAQ: GTHX
· Real-Time Price · USD
7.16
0.01 (0.14%)
At close: Sep 17, 2024, 9:56 PM
G1 Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -44.77M | -30.59M | -47.97M | -70.74M | -77.81M | -125.96M | -147.56M | -153.93M | -171.13M | -171.1M | -148.35M | -133.68M | -102.89M | -94.67M |
Depreciation & Amortization | 492K | 501K | 513K | 526K | 538K | 547K | 530K | 507K | 485K | 464K | 469K | 475K | 503K | 543K |
Stock-Based Compensation | 11.5M | 13.22M | 14.51M | 15.7M | 16.83M | 18.66M | 20.59M | 21.39M | 22.14M | 22.19M | 22.32M | 21.87M | 21.26M | 19.93M |
Other Working Capital | -6.84M | -7.36M | -3.98M | -3.41M | -214K | 6.65M | 8.39M | 10.15M | 12.11M | 2.52M | 759K | -15.04M | -7.18M | -2.96M |
Other Non-Cash Items | 5.17M | 226K | -190K | 10.73M | 2.06M | 2.73M | 3.13M | 3.47M | 3.02M | 2.58M | 1.7M | 1.19M | 1.23M | 288K |
Deferred Income Tax | 584K | n/a | n/a | -10.25M | -584K | n/a | n/a | 362K | 444K | 542K | 590K | 306K | 519K | 421K |
Change in Working Capital | -4.98M | -358K | -5.2M | -2.14M | -7.88M | -15.47M | -5.31M | -4.45M | -445K | 1.92M | -8.84M | -19.11M | -11.86M | -10.11M |
Operating Cash Flow | -37.54M | -18.18M | -38.34M | -56.18M | -66.85M | -119.49M | -128.62M | -132.65M | -145.48M | -143.41M | -132.11M | -128.96M | -91.24M | -83.6M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | -506K | -506K | -506K | -506K | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | 1K | 1K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -113.13M | -116.81M | -124.69M | -112.91M | -130.27M | -90.11M | -65.02M | -29.66M | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 118.2M | 122M | 127.5M | 103M | 83.5M | 43M | 15M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -445K | -99K | 2.81M | -9.9M | -46.77M | -47.11M | -50.02M | -29.66M | n/a | n/a | n/a | n/a | 152K | 152K |
Investing Cash Flow | 5.07M | 5.19M | 2.81M | -9.9M | -46.77M | -47.62M | -50.53M | -30.17M | -506K | n/a | n/a | n/a | 152K | 152K |
Debt Repayment | -9.88M | -35.44M | -26.69M | -26.69M | -25M | n/a | n/a | 45M | 45M | 45M | 55M | 10M | 10M | 30M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 1.17M | -265K | -505K | -290K | -1.87M | -120K | 112K | -1.1M | 858K | 2.34M | 4.43M | 6.15M | 4.35M | 3.58M |
Financial Cash Flow | -8.43M | -35.42M | -26.91M | 25.4M | 25.51M | 52.26M | 52.49M | 43.9M | 45.86M | 47.34M | 145.86M | 102.58M | 100.78M | 120.01M |
Net Cash Flow | -40.9M | -48.41M | -62.44M | -40.68M | -88.11M | -114.84M | -126.65M | -118.91M | -100.13M | -96.07M | 13.76M | -26.38M | 9.69M | 36.57M |
Free Cash Flow | -37.54M | -18.18M | -38.34M | -56.18M | -66.85M | -120M | -129.13M | -133.15M | -145.99M | -143.41M | -132.11M | -128.96M | -91.24M | -83.6M |